SCHEMBL3360264

SCHEMBL3360264

Cc1cc(=O)c(OCc2ccccc2)c(C(N)=O)[nH]1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.47
ALDH1A1 P00352 2/20 0.46
USP2 O75604 1/20 0.46
TSHR P16473 1/20 0.46
HSD17B10 Q99714 1/20 0.46
KDM4E B2RXH2 1/20 0.44
LMNA P02545 2/20 0.44
GAA P10253 1/20 0.44
PARP10 Q53GL7 1/20 0.43
HPGD P15428 2/20 0.43
MEN1 O00255 1/20 0.41
HTT P42858 1/20 0.41
KMT2A Q03164 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
GLRA1 P23415 1/20 0.40
PTPN1 P18031 1/20 0.40
CHEK2 O96017 1/20 0.40
THRA P10827 1/20 0.39
THRB P10828 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2117516 0.89 POLB (0.49) POLBALDH1A1USP2TSHRHSD17B10
SCHEMBL23843851 0.83 BRD4 (0.46) POLBALDH1A1USP2TSHRHSD17B10
SCHEMBL28223501 0.78 POLB (0.49) POLBALDH1A1USP2TSHRHSD17B10
SCHEMBL2981884 0.78 PDE2A (0.47) ALDH1A1USP2TSHRHSD17B10KDM4E
SCHEMBL21274657 0.77 POLB (0.61) POLBALDH1A1USP2TSHRHSD17B10
SCHEMBL2350824 0.74 MAP2 (0.52) POLBALDH1A1USP2TSHRHSD17B10
SCHEMBL338935 0.74 IDH1 (0.48) POLBALDH1A1KDM4ELMNAGAA
SCHEMBL3420123 0.73 ALDH1A1 (0.48) POLBALDH1A1USP2TSHRHSD17B10
SCHEMBL10590979 0.73 POLB (0.56) POLBALDH1A1USP2TSHRHSD17B10
SCHEMBL14539771 0.73 KDM4E (0.44) POLBALDH1A1KDM4ELMNAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100076199-A1 PROCESS FOR THE PREPARATION OF SUBSTITUTED PYRIDONE CARBOXYLIC ACIDS GE HEALTHCARE AS (NO) 2010-03-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100076199-A1 PROCESS FOR THE PREPARATION OF SUBSTITUTED PYRIDONE CARBOXYLIC ACIDS PNPO, PGD, PDXK POLB 530/4885ALDH1A1 1170/4885USP2 4454/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.